Biotechnology News

April 3, 2014

--(BUSINESS WIRE)--MdBio Foundation hosts ATLAS – a career symposium for high school juniors, seniors and college undergrads typically underrepresented in Science STEM fields.

April 3, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announces the...

April 3, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune Inc. (OTCQB:TPIV), A clinical stage immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease is pleased to update shareholders...

April 3, 2014

LONDON--(BUSINESS WIRE)--A delegation from one of the world’s leading universities, UCL (University College London) will be visiting Mexico from April 5th-12th to meet with some of the country’s top universities and organisations to discuss...

April 3, 2014

HEIDELBERG, Germany--(BUSINESS WIRE)--Novaliq GmbH today announced the commencement of a Phase 1 study for CyclASol (Cyclosporin solution) following US and European patent approval of the solution for the treatment of dry eye syndrome. While...

April 3, 2014

MANCHESTER, United Kingdom--(BUSINESS WIRE)--Cytox Ltd, (Cytox) a leading developer of assays for risk assessment and prediction of dementia, today announced the successful completion of a second round of funding, closing at £1.5M. New...

April 3, 2014

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that the first patients across the United States have received implants of the new Iforia implantable cardioverter-...

April 3, 2014

CARLSBAD, Calif. & SUZHOU, China--(BUSINESS WIRE)--The 2014 edition of ChinaBio® Partnering Forum, China’s only life science partnering event, is just weeks away, to be held May 7–8 at the Kempinski Hotel in Suzhou.

April 3, 2014

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it will conduct an intercontinental...

April 3, 2014

ST. LOUIS--(BUSINESS WIRE)--Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, today released the latest commercial version of the Broad Institute’s Genome Analysis Toolkit (GATK...

April 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Impact 2020 is an in-depth analysis and prediction of trends, opportunities and threats to life sciences in Massachusetts. This strategic report by MassBio is a call to action for stakeholders.

April 3, 2014

RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious...

April 3, 2014

MENLO PARK, Calif.--(BUSINESS WIRE)--Auxogyn, Inc., a company dedicated to advancing women’s reproductive health, today announced an exclusive license agreement with Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt.

April 3, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that positive preclinical results from an in vivo study of aldoxorubicin in an animal...

April 3, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ: KMDA)(TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today a U.S.-based proof-of-concept (POC) study with Glassia® to treat graft-...

April 3, 2014

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution

April 3, 2014

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today financial results for its third quarter ended February 28, 2014. Third Quarter Financial Results Consolidated net sales increased 6.6% (7.5% constant currency) worldwide to approximately...

April 2, 2014

WASHINGTON--(BUSINESS WIRE)--BIO and the Wireless-Life Sciences Alliance (WLSA) today announced the inaugural Digital Health Zone & Forum at the 2014 BIO International Convention, taking place June 23-26 in San Diego, CA

April 2, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced topline results from a Phase 3 clinical trial (Study GS-US-334-0118) in Japan evaluating the once-daily nucleotide analog polymerase inhibitor sofosbuvir in...

April 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced the appointment of Pankaj Bhargava, M.D., as Chief Medical Officer. Dr. Bhargava brings to...

April 2, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori announces that CEO Chris Calhoun will retire from the role of CEO effective immediately.

April 2, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS) today announced that it is offering $125 million of shares of its common stock in a proposed underwritten public offering. The offering is subject to market conditions and there...

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 13th Annual Needham Healthcare Conference on Wednesday,...

April 2, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the 13th Annual Needham Healthcare Conference being held April 8-9, 2014 at the Westin Grand Central Hotel in New York...

April 2, 2014

BROOMFIELD, Colo.--(BUSINESS WIRE)--Affygility Solutions announces the immediate availability of its occupational exposure limit (OEL) monograph for delta 9-tetrahydrocannabinol (THC), the active ingredient in marijuana.

April 2, 2014

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--VGTI Florida scientists awarded U.S. Patent No. 8,647,822 titled DETERMINING WHETHER A TEST COMPOUND MODULATES PD-1 ACTIVITY IN ACTIVATED IMMUNE CELLS USING GENE EXPRESSION PROFILES.

April 2, 2014

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix President and CEO Paul Hartung told a group of analysts yesterday: “Our vision is to change the course of Alzheimer’s disease by enabling early diagnosis at the point of care.” (CLICK HERE FOR VIDEO) Mr....

April 2, 2014

LONDON--(BUSINESS WIRE)--Process Systems Enterprise has acquired a significant equity stake in BlueWatt Engineering Sàrl, a company with unique technology for wastewater systems optimisation.

April 2, 2014

NEW YORK--(BUSINESS WIRE)--The staggering rise of Autism and the troubling lack of urgency by the medical establishment to address this crisis has led the founders of The Thinking Moms’ Revolution (authors of the book, The Thinking Moms’...

April 2, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Fresenius Kabi announced today that Dana-Farber Cancer Institute has received the company’s first Fresenius Kabi Scientific Investigator Award. The winning submission, “Extracorporeal Photopheresis Combined with...

April 2, 2014

HOUSTON--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that Pernix CEO Doug Drysdale is scheduled to present at the 13th Annual Needham...

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea will present at the Needham & Company 13th Annual Healthcare Conference on April 9, 2014.

April 2, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--23andMe Builds Out Leadership Team

April 2, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that it will have two poster presentations...

April 2, 2014

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to...

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pr-Clinical Research Shows ACC Inhibitors Dramatically Impact Tumor Growth in Small Cell Lung Cancer and Liver Cancer

April 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track designations for both the intravenous (IV) and oral formulations of the...

April 2, 2014

WOBURN, Mass.--(BUSINESS WIRE)--ArQule is scheduled to present at the Needham Healthcare Conference on April 9, 2014.

April 2, 2014

CHICAGO--(BUSINESS WIRE)--Navigant (NYSE: NCI) announced today that it has acquired substantially all of the Life Sciences practice of Leerink Swann Consulting, LLC, the consulting arm of Leerink Holdings, LLC, a leading investment bank...

April 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Richard A. Young, Syros Pharmaceuticals Scientific Founder, to Open AACR Annual Meeting 2014 with Address Highlighting His Pioneering Gene Control Research.

April 2, 2014

EAST PROVIDENCE, R.I.--(BUSINESS WIRE)--IlluminOss announces it has received a Notice of Allowance from the U.S. Patent and Trademark Office for instruments used in the company’s proprietary Photodynamic Bone Stabilization System (PBSS).

April 2, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--The Tech Council of Maryland announced today the finalists for its 26th Annual Industry Awards celebration.

April 2, 2014

PALO ALTO, Calif. & LEXINGTON, Mass.--(BUSINESS WIRE)--Syapse and N-of-One announced a partnership to make N-of-One’s clinical interpretation available to hospitals and laboratories through interfaces in the Syapse platform.

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana has received a patent with broad coverage over its Fleximer Antibody Drug Conjugate technology. Mersana's conjugation technology offers several improvements over existing ADC platforms.

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has adopted a positive...

April 2, 2014

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics announced the AEGIS-2 clinical trial has met its primary endpoint. Its BronchoGen genomic test improves the accuracy of lung cancer diagnosis in combination with bronchoscopy.